Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2601 ARTíCULOS , VIENDO DEL 61 AL 75

PUBMED

Dyspnea as a side effect of subthalamic nucleus deep brain stimulation for Parkinson's disease.

Chalif JI, Sitsapesan HA, Pattinson KT, Herigstad M, Aziz TZ, Green AL.

Respir Physiol Neurobiol. 2014 Feb 1;192:128-33. doi: 10.1016/j.resp.2013.12.014.

0

0

0

PUBMED

Association analysis of PARK16-18 variants and Parkinson's disease in a Chinese population.

Zhou LL, Zhang X, Bao QQ, Liu RP, Gong MY, Mao GY, Zou M, Zhu JH.

J Clin Neurosci. 2014 Jun;21(6):1029-32. doi: 10.1016/j.jocn.2013.09.015.

0

0

0

PUBMED

Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.

Pagonabarraga J, Soriano-Mas C, Llebaria G, López-Solà M, Pujol J, Kulisevsky J.

Parkinsonism Relat Disord. 2014 Mar;20(3):290-6. doi: 10.1016/j.parkreldis.2013.11.017.

0

0

0

PUBMED

Anhedonia in Parkinson's disease patients with and without pathological gambling: a case-control study.

Pettorruso M, Martinotti G, Fasano A, Loria G, Di Nicola M, De Risio L, Ricciardi L, Conte G, Janiri L, Bentivoglio AR.

Psychiatry Res. 2014 Feb 28;215(2):448-52. doi: 10.1016/j.psychres.2013.12.013.

0

0

0

PUBMED

Time course of dopamine neuron loss and glial response in the 6-OHDA striatal mouse model of Parkinson's disease.

Stott SR, Barker RA.

Eur J Neurosci. 2014 Mar;39(6):1042-56. doi: 10.1111/ejn.12459.

0

0

0

PUBMED

Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trial.

Ory-Magne F, Corvol JC, Azulay JP, Bonnet AM, Brefel-Courbon C, Damier P, Dellapina E, Destée A, Durif F, Galitzky M, Lebouvier T, Meissner W, Thalamas C, Tison F, Salis A, Sommet A, Viallet F, Vidail

Neurology. 2014 Jan 28;82(4):300-7. doi: 10.1212/WNL.0000000000000050.

0

0

0

PUBMED

Subthalamic nucleus activity dissociates proactive and reactive inhibition in patients with Parkinson's disease.

Benis D, David O, Lachaux JP, Seigneuret E, Krack P, Fraix V, Chabardès S, Bastin J.

Neuroimage. 2014 May 1;91:273-81. doi: 10.1016/j.neuroimage.2013.10.070.

0

0

0

PUBMED

Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study.

Yarnall AJ, Breen DP, Duncan GW, Khoo TK, Coleman SY, Firbank MJ, Nombela C, Winder-Rhodes S, Evans JR, Rowe JB, Mollenhauer B, Kruse N, Hudson G, Chinnery PF, O'Brien JT, Robbins TW, Wesnes K, Brooks

Neurology. 2014 Jan 28;82(4):308-16. doi: 10.1212/WNL.0000000000000066.

0

0

0

PUBMED

Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease.

Sala G, Stefanoni G, Arosio A, Riva C, Melchionda L, Saracchi E, Fermi S, Brighina L, Ferrarese C.

Brain Res. 2014 Feb 10;1546:46-52. doi: 10.1016/j.brainres.2013.12.017.

0

0

0

PUBMED

High beta activity in the subthalamic nucleus and freezing of gait in Parkinson's disease.

Toledo JB, López-Azcárate J, Garcia-Garcia D, Guridi J, Valencia M, Artieda J, Obeso J, Alegre M, Rodriguez-Oroz M.

Neurobiol Dis. 2014 Apr;64:60-5. doi: 10.1016/j.nbd.2013.12.005.

0

0

0

PUBMED

Jejunal levodopa infusion in Parkinson's disease.

Rascol O.

Lancet Neurol. 2014 Feb;13(2):128-9. doi: 10.1016/S1474-4422(13)70291-6. No abstract available.

0

0

0

PUBMED

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

Olanow CW, Kieburtz K, Odin P, Espay AJ, Standaert DG, Fernandez HH, Vanagunas A, Othman AA, Widnell KL, Robieson WZ, Pritchett Y, Chatamra K, Benesh J, Lenz RA, Antonini A; LCIG Horizon Study Group..

Lancet Neurol. 2014 Feb;13(2):141-9. doi: 10.1016/S1474-4422(13)70293-X. Erratum in: Lancet Neurol. 2014 Mar;13(3):240.

0

0

0

PUBMED

Leucine-rich repeat kinase 2 modulates cyclooxygenase 2 and the inflammatory response in idiopathic and genetic Parkinson's disease.

Lopez de Maturana R, Aguila JC, Sousa A, Vazquez N, Del Rio P, Aiastui A, Gorostidi A, Lopez de Munain A, Sanchez-Pernaute R.

Neurobiol Aging. 2014 May;35(5):1116-24. doi: 10.1016/j.neurobiolaging.2013.11.018.

0

0

0

PUBMED

Mood stability in Parkinson disease following deep brain stimulation: a 6-month prospective follow-up study.

Chopra A, Abulseoud OA, Sampson S, Lee KH, Klassen BT, Fields JA, Matsumoto JY, Adams AC, Stoppel CJ, Geske JR, Frye MA.

Psychosomatics. 2014 Sep-Oct;55(5):478-84. doi: 10.1016/j.psym.2013.09.003.

0

0

0

PUBMED

Imaging of olfactory bulb and gray matter volumes in brain areas associated with olfactory function in patients with Parkinson's disease and multiple system atrophy.

Chen S, Tan HY, Wu ZH, Sun CP, He JX, Li XC, Shao M.

Eur J Radiol. 2014 Mar;83(3):564-70. doi: 10.1016/j.ejrad.2013.11.024.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy